Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System
NCT ID: NCT02672150
Last Updated: 2019-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
839 participants
INTERVENTIONAL
2013-07-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preventing Adolescents From Entering the Juvenile Justice System
NCT02147743
Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse
NCT03035877
Enhancing Juvenile Drug Court Outcomes With Evidence-Based Practices
NCT01266109
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
NCT02130479
Randomized Trial of a Data-driven Technical Assistance System for Drug Prevention Coalitions
NCT04592120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods/design: The JJ-TRIALS primary study uses a head-to-head cluster randomized trial with a phased rollout to evaluate the differential effectiveness of two conditions (Core and Enhanced) in 36 sites located in 7 states. Core strategies for promoting change are compared to an Enhanced strategy that incorporate all core strategies plus active facilitation. Target outcomes include improvements in evidence-based screening, assessment, and linkage to substance use treatment.
Primary Research Questions:
1. Does the Core and/or Enhanced Intervention reduce unmet need by increasing Cascade retention related to screening, assessment, treatment initiation, engagement and continuing care?
2. Does the addition of the Enhanced Intervention components further increase the percentage of youth retained in the Cascade relative to the Core components?
3. Does the addition of the Enhanced Intervention components improve service quality relative to Core sites?
4. Do staff perceptions of the value of best practices increase over time, and are increases more pronounced in Enhanced sites?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
During the Baseline Control data is collected in all 36 sites at the agency, staff, and youth level on the 6 months prior to the interventions in Arms 2 \& 3 to document what practice was before the study.
No interventions assigned to this group
Core
In the second phase (after baseline) all 36 sites receive a Core condition that includes five interventions: (1) JJ-TRIALS Orientation Meetings, (2) Needs Assessment, (3) Behavioral Health Training, (4) Site Feedback Report, (5) Goal Achievement Training, (6) Monthly Site Check-ins, and (7) Quarterly Reports. As part of Goal Achievement Training, sites receive assistance in using their Site Feedback Reports to select goals to meet their local needs. Sites are trained on using Data-Driven Decision Making (DDDM) to inform decisions (e.g., selecting a goal, monitoring progress) and enlisting DDDM templates and tools (developed as part of the project) to plan and implement proposed changes.
these principles to their improvement efforts during the implementation phase.
Core
Enhanced
While the core intervention and DDDM are expected to facilitate change, organizations may need additional support to apply these principles to their improvement efforts during the implementation phase. In the third phase (after Core), 1/2 of the sites are randomly assigned to an Enhanced condition that provides continuing support for the use of DDDM tools by adding research staff facilitation of DDDM over a 12-month period and formalized Local Change Teams (LCTs) featuring representation from the JJ agency and a local BH provider, with meetings facilitated by research staff).
Core
Enhanced
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Core
Enhanced
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Youth inclusion criteria include: all youth entering the juvenile justice system during the period within the exception of those who are already in treatment at the time that they are referred to the juvenile justice agency.
Staff inclusion criteria include: all staff actively working with the youth under community supervision in the site with exclusion only of higher level administrative or regional staff over multiple units..
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Columbia University
OTHER
Emory University
OTHER
Mississippi State University
OTHER
Temple University
OTHER
Texas Christian University
OTHER
University of Kentucky
OTHER
Chestnut Health Systems
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael L. Dennis, Ph.D.
Coordinating Center Multi-PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tisha R Wiley, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute on Drug Abuse (NIDA)
Gail A Wasserman, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Ralph DiClemente, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Emory University
Gene H Brody, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Emory University
Angela A Robertson, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Mississippi State University
Steven R Belenko, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Temple University
Danica K Knight, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Texas Christian University
Carl G Leukefeld, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Kentucky
Michael L Dennis, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Chestnut Health Systems
Christy K Scott, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Chestnut Health Systems
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory University
Atlanta, Georgia, United States
Chestnut Health Systems
Bloomington, Illinois, United States
University of Kentucky
Lexington, Kentucky, United States
National Institute on Drug Abuse
Rockville, Maryland, United States
Mississippi State University
Starkville, Mississippi, United States
Columbia University
New York, New York, United States
Temple University
Philadelphia, Pennsylvania, United States
Texas Christian University
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jones SD, Bartkowski JP, Belenko S, Becan JE, Taxman FS, Wasserman GA, Aarons GA, McReynolds LS, Dolbear C, Xu X. Site engagement in implementation research: Introducing SEAMLIS as a conceptual and measurement framework. Health Justice. 2025 Jul 5;13(1):44. doi: 10.1186/s40352-025-00349-1.
Nelson V, Wood J, Belenko S, Pankow J, Piper K. Conditions of successful treatment referral practices with justice-involved youth: Qualitative insights from probation and service provider staff involved in JJ-TRIALS. J Subst Use Addict Treat. 2024 Jul;162:209358. doi: 10.1016/j.josat.2024.209358. Epub 2024 Mar 27.
Belenko S, Dembo R, Knight DK, Elkington KS, Wasserman GA, Robertson AA, Welsh WN, Schmeidler J, Joe GW, Wiley T. Using structured implementation interventions to improve referral to substance use treatment among justice-involved youth: Findings from a multisite cluster randomized trial. J Subst Abuse Treat. 2022 Sep;140:108829. doi: 10.1016/j.jsat.2022.108829. Epub 2022 Jun 19.
Marks KR, Leukefeld CG, Dennis ML, Scott CK, Funk R; JJ-TRIALS Cooperative. Geographic differences in substance use screening for justice-involved youth. J Subst Abuse Treat. 2019 Jul;102:40-46. doi: 10.1016/j.jsat.2019.04.005. Epub 2019 Apr 13.
Fisher JH, Becan JE, Harris PW, Nager A, Baird-Thomas C, Hogue A, Bartkowski JP, Wiley T; JJ-TRIALS Cooperative. Using Goal Achievement Training in juvenile justice settings to improve substance use services for youth on community supervision. Health Justice. 2018 Apr 30;6(1):10. doi: 10.1186/s40352-018-0067-4.
Becan JE, Bartkowski JP, Knight DK, Wiley TRA, DiClemente R, Ducharme L, Welsh WN, Bowser D, McCollister K, Hiller M, Spaulding AC, Flynn PM, Swartzendruber A, Dickson MF, Fisher JH, Aarons GA. A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi-site study. Health Justice. 2018 Apr 13;6(1):9. doi: 10.1186/s40352-018-0068-3.
Belenko S, Knight D, Wasserman GA, Dennis ML, Wiley T, Taxman FS, Oser C, Dembo R, Robertson AA, Sales J. The Juvenile Justice Behavioral Health Services Cascade: A new framework for measuring unmet substance use treatment services needs among adolescent offenders. J Subst Abuse Treat. 2017 Mar;74:80-91. doi: 10.1016/j.jsat.2016.12.012. Epub 2016 Dec 31.
Knight DK, Belenko S, Wiley T, Robertson AA, Arrigona N, Dennis M, Bartkowski JP, McReynolds LS, Becan JE, Knudsen HK, Wasserman GA, Rose E, DiClemente R, Leukefeld C; JJ-TRIALS Cooperative. Juvenile Justice-Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS): a cluster randomized trial targeting system-wide improvement in substance use services. Implement Sci. 2016 Apr 29;11:57. doi: 10.1186/s13012-016-0423-5.
Related Links
Access external resources that provide additional context or updates about the study.
JJTRIALS home page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JJ-TRIALS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.